Lupin Limited — Updates, 02-02-2026: Press Release
02-02-2026 | 10:08 am
02-02-2026 | 10:08 am
Lupin collaborates with TB Alliance to advance Telacebec's clinical development and commercialization for tuberculosis & other mycobacterial diseases. Lupin will leverage its manufacturing and supply chain expertise for global access to the investigational drug.
No comments yet. Be the first to comment!
